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Plasma Membrane and the
Mechanisms That Influence It
Mary L. Kraft *
Department of Chemical and Biomolecular Engineering, University of Illinois, Urbana, IL, USA
Sphingolipids are structural components in the plasma membranes of eukaryotic cells.
Their metabolism produces bioactive signaling molecules that modulate fundamental
cellular processes. The segregation of sphingolipids into distinct membrane domains
is likely essential for cellular function. This review presents the early studies of
sphingolipid distribution in the plasma membranes of mammalian cells that shaped
the most popular current model of plasma membrane organization. The results
of traditional imaging studies of sphingolipid distribution in stimulated and resting
cells are described. These data are compared with recent results obtained with
advanced imaging techniques, including super-resolution fluorescence detection and
high-resolution secondary ion mass spectrometry (SIMS). Emphasis is placed on the new
insight into the sphingolipid organization within the plasma membrane that has resulted
from the direct imaging of stable isotope-labeled lipids in actual cell membranes with
high-resolution SIMS. Super-resolution fluorescence techniques have recently revealed
the biophysical behaviors of sphingolipids and the unhindered diffusion of cholesterol
analogs in the membranes of living cells are ultimately in contrast to the prevailing
hypothetical model of plasma membrane organization. High-resolution SIMS studies
also conflicted with the prevailing hypothesis, showing sphingolipids are concentrated
in micrometer-scale membrane domains, but cholesterol is evenly distributed within
the plasma membrane. Reductions in cellular cholesterol decreased the number of
sphingolipid domains in the plasma membrane, whereas disruption of the cytoskeleton
eliminated them. In addition, hemagglutinin, a transmembrane protein that is thought
to be a putative raft marker, did not cluster within sphingolipid-enriched regions in the
plasmamembrane. Thus, sphingolipid distribution in the plasmamembrane is dependent
on the cytoskeleton, but not on favorable interactions with cholesterol or hemagglutinin.
The alternate views of plasma membrane organization suggested by these findings are
discussed.
Keywords: sphingolipid distribution, plasma membrane organization, lipid domains, secondary ion mass
spectrometry, SIMS, imaging
INTRODUCTION
The plasma membranes of mammalian cells contain many different lipid species, but the
distribution of sphingolipids within the plasma membrane and the mechanisms responsible for
this organization are of particular interest. Sphingolipids function as structural components in
cellular membranes, and they are metabolized to signaling molecules that modulate diverse cellular
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processes, ranging from apoptosis (Herr et al., 1997; Carpinteiro
et al., 2008; Yabu et al., 2015) to cytoskeletal reorganization
(Bartke and Hannun, 2009; Milhas et al., 2010; Gandy et al.,
2013; Adada et al., 2014). Regulation of sphingolipid metabolite
signaling likely involves segregating the parent sphingolipid
molecules within distinct plasma membrane domains, but
the distributions of various sphingolipids within the plasma
membrane are not well established. At present, the different
subspecies within the sphingolipid family are known to vary
in terms of their chemical properties, expression patterns,
specific protein binding partners, and consequently, specialized
functions (Hannun and Bell, 1989; Mutoh et al., 1995; Snook
et al., 2006; Yu et al., 2011; Contreras et al., 2012; Fantini and
Yahi, 2015; Prasanna et al., 2016). These divergent properties
and functions may suggest that each sphingolipid subspecies
is compartmentalized within a different region of the plasma
membrane. Nonetheless, most studies have focused on just a few
types of sphingolipid-enriched plasma membrane domains: lipid
rafts and ceramide-rich domains.
The lipid raft is likely the most intensely studied sphingolipid
domain that hypothetically exists in the plasma membrane.
Lipid rafts are defined as small (<200 nm) and dynamic
plasma membrane domains that are enriched with cholesterol,
sphingolipids, and glycosylphosphatidylinositol (GPI)-anchored
proteins (Pike, 2006; Lingwood and Simons, 2010; Nyholm, 2015;
Levental and Veatch, 2016). Favorable interactions between the
cholesterol and sphingolipids are widely thought to drive lipid
raft formation, producing higher ordering within this domain
than in the surrounding membrane (Simons and Ikonen, 1997;
Rietveld and Simons, 1998). GPI-anchored proteins and some
transmembrane proteins are postulated to have an affinity for
the distinct chemical and physical environment within the
lipid raft, which hypothetically promotes their association with
these domains and interactions between the proteins within
them (Simons and Ikonen, 1997; Lingwood and Simons, 2010;
Levental and Veatch, 2016). Protein-protein interactions are
proposed to stabilize the small and dynamic rafts, leading to
the formation of larger structures (Harder and Simons, 1999;
Nyholm, 2015; Simons, 2016). Lipid rafts are hypothesized to
mediate many important cellular processes, including protein
trafficking, signal transduction, and virus budding (Scheiffele
et al., 1999; Nguyen and Hildreth, 2000; Simons and Toomre,
2000; Schuck and Simons, 2004; Ono and Freed, 2005; Luo
et al., 2008; Takahashi and Suzuki, 2011). The postulated higher
ordering of the sphingolipids, cholesterol, and proteins within
lipid rafts was thought to make these putative domains insoluble
in cold ionic detergents (Schroeder et al., 1994; Ahmed et al.,
1997; Cremesti et al., 2002; Zajchowski and Robbins, 2002).
Consequently, detergent extraction was once widely used to study
lipid rafts. Detergent-resistant membranes isolated from cells
later proved to be artificial structures that were not present
in vivo (Lichtenberg et al., 2005). This increased the importance
of imaging putative raft components, such as sphingolipids and
GPI-anchored proteins, within intact cell membranes.
Ceramide-rich domains in the plasma membrane have
also been the subject of many studies. These domains are
produced by the hydrolysis of sphingomyelin to ceramide by
sphingomyelinase in response to stimuli (i.e., multivalent binding
to membrane receptors; Cremesti et al., 2001; Bollinger et al.,
2005). Like lipid rafts, ceramide-rich domains are postulated to
exhibit high ordering that enhances the recruitment of GPI-
anchored proteins, which modulates their interactions with other
membrane proteins (Cremesti et al., 2002; Bollinger et al., 2005).
However, ceramide-rich domains are large enough to be detected
with light microscopy, and they putatively lack cholesterol
enrichment (Cremesti et al., 2002; Bollinger et al., 2005). In this
review, ceramide-rich domains are defined solely according to
their enrichment with ceramide, irrespective of their cholesterol
or protein content.
The following sections describe the sphingolipid distributions
that have been imaged in resting cells with a variety of techniques,
and how these organizations are affected by various stimuli.
Due to space limitations, this review focuses on reports that
contextualize the development of current models of plasma
membrane organization, and the results that that have led some
to question or even reject the raft hypothesis (Shaw, 2006;
Kenworthy, 2008; Kraft, 2013; Sevcsik and Schütz, 2016;Wüstner
et al., 2016). Emphasis is placed on the findings acquired with a
new approach for chemically mapping isotope-labeled lipids in
the plasmamembrane with high-resolution, which were reported
by the author and collaborators. Finally, the implications of these
findings on models of sphingolipid organization in the plasma
membrane are discussed.
METHODS TO IMAGE SPHINGOLIPID
DISTRIBUTION IN THE PLASMA
MEMBRANES OF MAMMALIAN CELLS
In order to visualize the sphingolipids within the plasma
membrane, they must be functionalized with a label that can
be detected with an imaging technique. A variety of lipid
probes and detection methods have been employed, each having
distinct advantages and disadvantages. One of the most common
strategies to date is to use an affinity tag, such as an antibody or
toxin, to label the sphingolipid species of interest. Noteworthy,
non-toxic recombinant versions of toxin molecules that retain
their sphingolipid-binding properties have been developed to
permit live-cell imaging without adversely affecting cell viability
(Kishimoto et al., 2016). The affinity tag is usually conjugated
to a fluorophore or heavy metal particle that can be visualized
with fluorescence or immunoelectron microscopy, respectively.
Alternatively, the affinity tag is labeled with a second affinity
tag (i.e., a polyclonal antibody) that has been functionalized to
permit detection. This approach is attractive because it enables
attaching any desired detection probe to endogenous lipids on
the cell surface. The main limitation is that only a fraction of the
lipid molecules of interest can typically be labeled and detected
with an affinity label. This low detection efficiency is primarily
due to three factors. First, affinity labels often cannot access
the entire cell surface due to their relatively large size; second,
lipids that are already bound to endogenous proteins cannot
be detected; third, affinity label binding often depends on the
specific orientation and/or clustering of the target lipid (Mahfoud
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et al., 2010; Mizuno et al., 2011; Kishimoto et al., 2016). Another
disadvantage is that some anti-glycosphingolipid antibodies and
the popular affinity label for GM1, cholera toxin subunit B, may
also bind to glycoproteins, which compromises their ability to
report the distribution of the target glycosphingolipid (Tonegawa
and Hakomori, 1977; Blank et al., 2007; Day and Kenworthy,
2012; Wands et al., 2015).
The direct imaging of fluorophore-labeled sphingolipid
analogs incorporated into the membranes of living cells has
been gaining popularity. These fluorescent sphingolipid analogs
are advantageous because they afford more flexibility in terms
of fluorophore selection, and they can be employed for live
cell imaging. Fluorescent sphingolipid precursors that permit
observing the lipid distribution that results from biosynthesis
and trafficking have also been developed (Peters et al., 2007;
Kim et al., 2013). The main drawback to this approach is that
the relatively large and chemically distinct fluorophore may
alter the interactions between the labeled sphingolipid and other
membrane components, which can change the lipid distribution
in the membrane (Devaux et al., 2002; Maier et al., 2002; Shaw
et al., 2006).
The sphingolipid distribution in the plasma membranes
of intact cells has also been imaged with a high-resolution
secondary ion mass spectrometry (SIMS) technique. High-
resolution SIMS performed on a commercial instrument, the
Cameca NanoSIMS 50, enables visualizing the distributions of
metabolically incorporated stable isotope-labeled lipids in the
plasma membranes of intact cells with better than 100 nm
lateral resolution (Klitzing et al., 2013; Kraft and Klitzing, 2014).
The principles of SIMS performed with a Cameca NanoSIMS
50 instrument have been previously described in detail (Boxer
et al., 2009; Kraft and Klitzing, 2014). Therefore, the following
description emphasizes the aspects of the technique that affect
its application to imaging the lipid distribution in the plasma
membranes of intact cells.
During NanoSIMS analysis, a cesium primary ion beam with
a diameter of ∼70 nm is raster scanned across the surface of the
cell. The molecules within the beam’s focal area are fragmented
into small pieces, and the charged particles, which are called
secondary ions, are ejected from the surface (top 5–10 nm) of the
sample. This shallow depth of secondary ion ejection minimizes
the detection of secondary ions from intracellular membranes,
thereby restricting the analysis to the plasma membrane. The
high-yielding monoatomic and diatomic secondary ions are
collected by a mass spectrometer that can discriminate between
ions that have the same nominal mass but different isotopic or
elemental compositions (i.e., 13C14N− at 27.0059 and 12C15N−
at 26.9996 amu). The intensities of the secondary ions detected
at each pixel reveal the elemental and isotopic composition at the
surface of the sample. Because elemental composition cannot be
used to distinguish between lipid species, the sphingolipids must
be labeled with distinct stable isotopes to allow their identification
with a NanoSIMS instrument. This is achieved by metabolic
labeling with isotope-labeled lipid precursors (Klitzing et al.,
2013).
The strengths and weaknesses of high-resolution SIMS
are complementary to those of imaging affinity tagged or
fluorophore-labeled lipids with fluorescence microscopy. The
strengths are that the stable isotope labels do not change the
labeled lipid’s chemical structure or molecular interactions, so
its intracellular trafficking and distribution are not perturbed.
Additionally, because distinct stable isotopes can be selectively
and metabolically incorporated into the majority of the cellular
sphingolipids, most sphingolipid molecules within the plasma
membrane can be detected. The primary disadvantage is that
this technique is performed under ultrahigh vacuum (UHV),
so the cells must be dehydrated prior to analysis. However,
previous studies demonstrate that chemical fixation techniques
that crosslink the proteins with glutaraldehyde and the lipids
with osmium tetroxide (OsO4) preserve the laminar structure of
biological membranes and prevent lipid reorganization during
sample dehydration and subsequent analysis (Stoechenius et al.,
1960; Frisz et al., 2013b). Consequently, the NanoSIMS images
acquired from chemically fixed cells represent snapshots of the
lipid organizations that were present in the moments prior to
fixation.
The following sections summarize some of the results that
have been acquired with the aforementioned approaches. Studies
that used fluorescence or immunoelectron microscopy to detect
sphingolipid-specific affinity tags to probe the involvement of
a specific type of sphingolipid domain in cell response to
external stimuli (i.e., involvement of lipid rafts or ceramide-
rich domains in receptor clustering) are presented first.
Next, studies that employed affinity-labeled sphingolipids and
fluorescent sphingolipid analogs to visualize the distributions
of specific sphingolipid subspecies in the plasma membranes of
unstimulated cells are described. This includes a brief account
of the insights into plasma membrane organization that were
acquired with super-resolution fluorescence techniques. Then the
sphingolipid distributions that have been imaged in the plasma
membranes of intact mammalian cells with high-resolution SIMS
are summarized. Finally, the implications of these experimental
results on our view of plasma membrane organization are
discussed.
GLYCOSPHINGOLIPID REDISTRIBUTION
INDUCED BY ANTIGEN CROSSLINKING
Antibody binding to proteins on the surfaces of lymphocytes
was first reported to induce the crosslinked proteins to form
clusters that eventually segregate into a large patch, or “cap”
at one end of the cell in 1971 (Taylor et al., 1971). Subsequent
reports showed this capping is inhibited by drug treatments
that impair microtubules (De Petris, 1974), and it can be
induced on any motile mammalian cell by crosslinking its
surface antigens with multivalent ligands, such as antibodies
(Bretscher, 1984). An early hypothesis for the crosslinking-
induced capping of membrane proteins postulated that cell
surface proteins are associated with cytoskeletal components
that actively cluster the crosslinked membrane proteins in
response to multivalent binding interactions (de Petris, 1977).
This hypothesis predicts that crosslinking the glycosphingolipids
that reside in the outer leaflet of the plasma membrane would
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not induce capping because these glycosphingolipids are not
in direct contact with the cytoskeletal components in the
cytoplasm. This prediction motivated the earliest efforts to
characterize sphingolipid distribution in the plasma membrane
in response to antigen capping. In 1975, Revesz and Greaves
tested the prediction by labeling the GM1 in the plasma
membranes of immune cells with cholera toxin, crosslinking
the toxin with horse anti-cholera serum, and then labeling with
fluorescent anti-horse secondary antibodies for visualization.
They found the fluorescently labeled and crosslinked GM1
redistributed into multimicrometer-scale caps on the surfaces
of the immune cells (Revesz and Greaves, 1975). The same
year, Craig and Cuatrecasas reported that solely the binding
of fluorescently labeled cholera toxin to GM1 was sufficient to
induce the formation of large GM1 clusters on the surfaces of rat
lymphocytes (Craig and Cuatrecasas, 1975). Like the capping of
proteinaceous antigens, GM1 capping was inhibited bymetabolic
poisons and drugs that inhibit microtubules and microfilaments
(Craig and Cuatrecasas, 1975; Revesz and Greaves, 1975).
The sensitivity to microtubule and microfilament inhibitors
implied that GM1 capping was mediated by cytoskeletal
components. This unexpected implication instigated concerns
that cholera toxin crosslinks both GM1 and glycosylated
membrane proteins, and the observed capping was orchestrated
by the cytoskeletal components associated with the crosslinked
membrane glycoproteins.
Subsequent studies confirmed that capping could be induced
by crosslinking glycosphingolipids with multivalent ligands
other than cholera toxin. Exogenous Forssman glycolipid, a
neutral glycosphingolipid consisting of five monosaccharides,
inserted into mouse thymocytes could be capped by labeling
it with a monoclonal primary antibody and then crosslinking
with secondary antibodies (Stern and Bretscher, 1979). This
capping was inhibited by chemically fixing the cells prior
to crosslinking with the secondary antibody, and consistent
with prior reports, by treatment with metabolic poisons or
inhibitors of microfilaments and microtubules (Stern and
Bretscher, 1979). Antibody crosslinking of the Forssman
glycosphingolipid and globoside, a neutral glycosphingolipid
with four monosaccharides, induced their aggregation in the
membranes of erythrocytes (Tillack et al., 1983). However, anti-
glycosphingolipid antibodies were reported to have an affinity for
glycoproteins (Tonegawa and Hakomori, 1977), so these findings
did not dissuade concerns that the observed capping was actually
induced by the crosslinking of cell surface glycoproteins.
Spiegel and coworkers performed similar studies using
gangliosides functionalized with non-native haptens (i.e.,
fluorophores) or biotin that could be crosslinked with antibodies
or avidin, respectively, to ensure that the glycosphingolipid
crosslinker had no affinity for endogenous proteins. The
crosslinking of these exogenously incorporated gangliosides
in the membranes of lynphocytes induced the formation of
large patches and caps (Spiegel et al., 1979, 1984; Spiegel and
Wilchek, 1981). Interestingly, anti-rhodamine antibodies elicited
the co-aggregation of both rhodamine-labeled gangliosides
and Lucifer yellow-labeled gangliosides on lymphocytes that
contained both labeled gangliosides. However, anti-rhodamine
antibodies did not induce the capping of Lucifer yellow-labeled
gangliosides on lymphocytes that lacked rhodamine-labeled
gangliosides (Spiegel et al., 1984). These experiments clearly
demonstrate that capping can be induced by the crosslinking of
glycosphingolipids, and also suggest that different gangliosides
interact with one another within the plasma membrane.
The finding that metabolic poisons and inhibitors of
cytoskeletal components impede glycosphingolipid capping
(Craig and Cuatrecasas, 1975; Revesz and Greaves, 1975; Stern
and Bretscher, 1979) implies that this capping involves
energy-dependent cytoskeletal reorganization. But how
could glycosphingolipid capping be mediated by cytoskeletal
reorganization if the crosslinked glycosphingolipids on the cell
surface do not contact the cytoplasm where cytoskeletal proteins
reside? One hypothesis proposed that the glycosphingolipids
selectively bind to membrane proteins that are associated
with cytoskeletal components, and ligand binding induces
cytoskeletal reorganization that actively clusters the crosslinked
glycosphingolipids (Craig and Cuatrecasas, 1975; Bourguignon
and Singer, 1977; Kellie et al., 1983). By the early 1980s, several
reported observations indirectly supported this hypothetical
model for glycosphingolipid capping. They included the
detection of glycosphingolipids in isolated membrane protein
complexes (Ji, 1974; Lingwood et al., 1980), the association
of GM1 with cytoskeletons produced by detergent treatment
(Sahyoun et al., 1981; Streuli et al., 1981; Hagmann and Fishman,
1982), and the accumulation of cytoskeletal proteins under
the patches of crosslinked glycosphingolipids in intact cells
(Kellie et al., 1983). An alternative hypothetical mechanism for
ganglioside capping proposed that gangliosides self-associate
with one another in resting cells, and crosslinking pulls these
tiny ganglioside clusters together, forming larger lipid patches
(Spiegel et al., 1984; Thomas et al., 1994). This hypothesis is
consistent with the finding that GM1 crosslinking induced
the co-capping of both GM1 and GM3 (Spiegel et al., 1984).
However, this hypothetical mechanism for crosslinking-induced
ganglioside capping did not predict a role for cytoskeletal
components, or consequently, the impairment of ganglioside
capping by metabolic poisons and inhibitors of cytoskeletal
components.
The idea that lipid self-association drives the formation of
distinct lipid domains that mediate capping and subsequent
signal transduction further developed into the lipid raft
hypothesis. This hypothesis states that attractive forces between
sphingolipid and cholesterol molecules within the plasma
membrane give rise to ordered cholesterol- and sphingolipid-
enriched domains that are called lipid rafts (Simons and Ikonen,
1997). GPI-anchored proteins are hypothesized to have an
affinity for, and thus concentrate within lipid rafts, thereby
promoting their interactions with other raft-associated signaling
proteins (Simons and Ikonen, 1997). The presence of lipid
rafts at the site of antigen patching was inferred from the co-
patching of crosslinked receptors and gangliosides, which are
purportedly integral lipid raft components, on the surfaces of
immune cells (Stauffer and Meyer, 1997; Harder et al., 1998).
Clusters of GPI-anchored receptors and gangliosides were not
detected on cells without crosslinking (Mayor et al., 1994; Mayor
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and Maxfield, 1995; Fujimoto, 1996). Therefore, GPI-anchored
proteins were hypothesized to reside in tiny lipid rafts that
nucleate into structures that can be detected with conventional
fluorescence microscopy when crosslinked (Harder et al., 1998).
Actin accumulated under the crosslinked antigen patches, so
these larger protein clusters were hypothesized to represent the
coalescence of lipid rafts into larger domains that were stabilized
by the actin cytoskeleton and its associated proteins (Ash et al.,
1977; Bourguignon and Singer, 1977; Kellie et al., 1983; Pierini
et al., 1996; Harder and Simons, 1999). The hypothesis that
lipid raft clustering is responsible for the patching of crosslinked
antigens was bolstered by the early finding that the co-clustering
of crosslinked GPI-anchored proteins and GM1 was reduced
by cholesterol depletion, which ostensibly eliminates lipid rafts
(Harder et al., 1998; Harder and Simons, 1999).
The hypothetical role of lipid rafts in antigen patching
stimulated new efforts to image the glycosphingolipid
reorganization induced by antigen crosslinking. Based on
the assumptions that GM1 and other gangliosides are markers
for lipid rafts, and favorable cholesterol-sphingolipid interactions
drive lipid raft formation, many studies focused on imaging GM1
proximity to crosslinked antigens and the effects of cholesterol
depletion. These studies confirmed that antigen crosslinking
induces local elevations in the fluorescence signals from both
the crosslinked GPI-anchored protein and toxin-crosslinked
GM1, and this co-clustering is inhibited by cholesterol depletion
(Stauffer and Meyer, 1997; Harder et al., 1998; Huby et al., 1999;
Janes et al., 1999; Grassmé et al., 2001a; Mitchell et al., 2002).
Subsequent reports also confirmed that cytoskeletal elements
accumulate under the site of antigen patching (Rodgers and
Zavzavadjian, 2001; Delaguillaumie et al., 2004; Wilson et al.,
2004).
Though many reports verified the signals from GM1
and the clustered membrane proteins were colocalized at
the resolution of conventional fluorescence microscopy, other
reports challenged the interpretation of this co-localization as
evidence for antigen clustering in rafts. Fluorescence resonance
energy transfer (FRET) studies indicated a lack of true co-
localization between GPI-anchored proteins and cholera toxin-
labeled GM1 (Kenworthy et al., 2000; Glebov and Nichols, 2004).
The energy transfer between the antibody-labeled GPI-anchored
proteins and cholera toxin B-labeled GM1 correlated with their
surface densities, and were not selectively colocalized, which
is inconsistent with GPI-anchored protein recruitment to lipid
rafts (Kenworthy et al., 2000; Glebov and Nichols, 2004). The
local increases in fluorescence from GPI-anchored proteins and
cholera toxin-labeled GM1 observed after antigen crosslinking
could instead be attributed to a local excess of cell membrane.
Consistent with this conclusion, another report clearly showed
numerous membrane folds and protrusions were present at
the site where the fluorescence signals from the GPI-anchored
proteins and cholera toxin-labeled GM1were elevated on a Jurkat
cell (Glebov and Nichols, 2004). An immunoelectronmicroscopy
study also challenged the finding that crosslinked GPI-anchored
proteins co-cluster with GM1. This work revealed a lack of
GM1 enrichment in patches of crosslinked putative raft proteins,
namely the GPI-anchored protein Thy-1 and the IgE receptor
(Wilson et al., 2004), which argues that these crosslinked antigens
do not reside in lipid rafts. Consequently, the observed patching
of Thy-1 and IgE receptor could not have beenmediated by either
lipid rafts or the favorable cholesterol-sphingolipid interactions
that hypothetically drive raft formation.
Recent reports that cholesterol depletion perturbs cytoskeletal
organization (Ramprasad et al., 2007; Sun et al., 2007; Qi
et al., 2009; Norman et al., 2010; Chubinskiy-Nadezhdin
et al., 2013; Dick et al., 2013) may suggest that cholesterol
depletion inhibits antigen patching by preventing the cytoskeletal
proteins from actively clustering the crosslinked antigens. But,
as mentioned above, if the cytoskeleton, and not lipid rafts,
mediates the clustering of crosslinked antigens, the finding
that crosslinking induces glycosphingolipid capping implies the
glycosphingolipids in the outer leaflet of the plasma membrane
are indirectly associated with cytoskeletal proteins. Studies of
the trafficking of GD3, a disialoganglioside ganglioside, during
CD95/Fas-mediated apoptosis seem to support this possibility.
CD95/Fas-mediated apoptosis is initiated by the binding of either
the Fas ligand or an antagonistic Fas antibody to CD95, a
member of the TNF-receptor superfamily that is also called Fas
(Wajant, 2014). This binding induces the recruitment of Fas-
associated death domain (FADD) to the CD95 death domain.
Next, procaspase-8 is recruited to FADD’s death effector domain,
forming the death-inducing signaling complex (DISC) that
elicits apoptosis (Algeciras-Schimnich et al., 2002; Wajant, 2014).
Interest in GD3 involvement in CD95/Fas-mediated apoptosis
began with the discovery that the crosslinking of CD95 on
lymphoid and myeloid cells induces GD3 production, and this
ganglioside is required for apoptosis (De Maria et al., 1997).
Immunoelectron and immunofluorescence imaging of GD3 and
organelle markers in hepatocytes treated with tumor necrosis
factor-α (TNF-α) revealed that GD3 moved from the plasma
membrane to mitochondria prior to mitochondrial membrane
depolarization and apoptosis (Garcıa-Ruiz et al., 2002). Malorni
and coworkers identified multiple cytoskeletal proteins that GD3
may associate with during its transit tomitochondria in lymphoid
cells treated with anti-CD95 antibodies. GD3 association with
ezrin was suggested by the co-localization between ezrin and
GD3 observed with immunofluorescence microscopy, and by
the presence of GD3 in immunoprecipitates obtained with anti-
ezrin monoclonal antibodies (Giammarioli et al., 2001). Another
study by Malorni and coworkers provided strong evidence that
GD3 also associates with tubulin (Sorice et al., 2009). This
evidence includes the elevated FRET efficiency between GD3 and
β-tubulin that was detected after Fas ligation, immunoelectron
images showing immunogold-labeled GD3 on microtubules,
and the presence of GD3 in immunoprecipitates obtained with
anti-tubulin antibodies (Sorice et al., 2009). Furthermore, an
in silico docking analysis predicted GD3 has a high affinity
for a pore on polymerized tubulin, indicating selective GD3-
tubulin interactions (Sorice et al., 2009). A subsequent FRET
study revealed that GD3 colocalized with CLIPR-59, a tubulin-
binding protein, shortly before it colocalized with tubulin (Sorice
et al., 2010). Based on the assumption that GD3 is a marker
for lipid rafts, it had been proposed that GD3 trafficking
involved interactions between lipid rafts and the cytoskeleton
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(Giammarioli et al., 2001; Sorice et al., 2009, 2010). However,
these results also support an alternative hypothesis that GD3
trafficking is mediated by the selective binding of individual GD3
molecules directly to proteins associated with the cytoskeleton in
absence of lipid rafts.
Overall, the results described in this section clearly
demonstrate that the crosslinking of glycosphingolipids
induces their redistribution into patches on the surfaces of
immune cells. However, they fail to conclusively establish
whether either favorable interactions between cholesterol
and sphingolipids or specific glycosphingolipid-protein
interactions are the driving force for this glycosphingolipid
reorganization.
CERAMIDE-RICH MEMBRANE DOMAINS
INDUCED BY EXTERNAL STIMULI
Ceramide’s role as a second messenger that directly participates
in signaling cascades began to gain recognition in the early
1990’s (Kim et al., 1991; Dobrowsky and Hannun, 1992;
Bielawska et al., 1993; Dobrowsky et al., 1993; Obeid et al.,
1993; Cifone et al., 1994; Hannun, 1994). By the late 1990’s,
various stimuli were known to activate sphingomyelinases that
hydrolyze sphingomyelin to ceramide, producing a transient
increase in ceramide levels that is required for biological response
(Wiegmann et al., 1994; Tepper et al., 1995; Grassmé et al., 1997;
Brenner et al., 1998; Junge et al., 1999; Grullich et al., 2000). This
section describes studies that probed the subcellular localization
of sphingomyelinase and the ceramide it produces in response to
external stimuli.
Among the stimuli that induce ceramide generation is the
crosslinking of CD95 (Cifone et al., 1994; Tepper et al., 1995;
Brenner et al., 1998; Grullich et al., 2000), which also induces
GD3 production and its trafficking within the cell (vide supra).
Immunoimaging studies established that CD95 activation
induces acid sphingomyelinase translocation to the cell surface
and subsequent CD95 clustering (Grassmé et al., 2001a; Lacour
et al., 2004). Ceramide generation in the plasma membrane was
initially postulated to occur in caveolae, which are flask-shaped
plasma membrane invaginations that consist of the caveolin-1
structural protein (Liu and Anderson, 1995; Bilderback
et al., 1997). This hypothesis was based on the finding that
sphingomyelin levels decreased and ceramide levels increased in
a caveolin-rich detergent-insolublemembrane fraction that could
be isolated from cells (Liu and Anderson, 1995; Bilderback et al.,
1997). The caveolin-containing detergent insoluble membrane
fraction was also enriched with cholesterol, sphingolipids,
and GPI-anchored proteins, so after the raft hypothesis was
proposed, ceramide generation was postulated to occur in
lipid rafts (Grassmé et al., 2001a). Efforts to investigate this
hypothesis often combined immunolabels for sphingomyelinase
detection with the aforementioned strategies used to assess
the involvement of lipid rafts in receptor clustering, such as
imaging immunolabeled GM1 as a proxy for rafts and probing
the effects of cholesterol depletion. These studies demonstrated
that after translocation to the cell surface, the signals from
the acid sphingomyelinase overlapped with those from the
clustered CD95 and cholera toxin-labeled GM1 on the surfaces
of CD95-activated cells (Grassmé et al., 2001a; Bock et al., 2003).
Depletion of cellular cholesterol reduced acid sphingomyelinase
translocation to the cell surface, subsequent CD95 clustering,
and CD95-induced apoptosis (Cremesti et al., 2001; Grassmé
et al., 2001a; Lacour et al., 2004). The authors concluded that
acid sphingomyelinase is transported to lipid rafts where it
generates the ceramide that is required for receptor clustering
and subsequent apoptosis. Noteworthy, this conclusion hinges
on the assumptions that GM1 primarily resides in lipid rafts,
and that cholesterol depletion eliminates lipid rafts without
perturbing specific protein-protein or cholesterol-protein
interactions.
The use of new ceramide-specific affinity labels to study
the role of ceramide generation in receptor clustering yielded
compelling evidence for the existence of ceramide-rich domains
in the plasma membrane (Grassmé et al., 2001b, 2002; Bock
et al., 2003; Lacour et al., 2004). Immunofluorescence imaging
of a fluorescently labeled protein construct with an affinity for
ceramide revealed large fluorescent patches at the perimeters
of CD95-stimulated Jurkat cells (Grassmé et al., 2001b). CD95
clustering was inhibited by treating the cells with proteins that
bind to the ceramide on the cell surface prior to CD95 activation,
and by inhibition of acid sphingomyelinase, which confirms
ceramide generation is required for biological response (Grassmé
et al., 2001b). A subsequent report that employed anti-ceramide
antibodies to detect ceramide also indicated the presence of
large ceramide-rich patches on CD95-activated colon cancer
cells that had been treated with the anticancer drug cisplatin
(Lacour et al., 2004). Overlap between the large patches of
ceramide-specific fluorescence and the clustered CD95 at the
cell periphery was detected with immunofluorescence imaging;
neither patches of ceramide-specific fluorescence nor CD95
clusters were found on untreated cells (Lacour et al., 2004).
The possibility that the elevated patches of fluorescence from
the ceramide-specific affinity labels detected in these studies
may signify an excess of membrane caused by membrane
folds and protrusions has not been directly assessed. However,
electron microscopy images of intact and sectioned cells
demonstrated that acid sphingomyelinase was localized within
distinct regions on the surfaces of CD95-activated cells, and
was not evenly distributed on their surfaces (Grassmé et al.,
2001a,b). Because the production of ceramide on the cell surface
is catalyzed by acid sphingomyelinase, this compartmentalized
acid sphingomyelinase distribution indicates ceramide is
produced at discrete regions on the cell surface. Consequently,
the elevated patches of ceramide-specific fluorescence
observed in the studies described above likely represent
ceramide-enriched membrane domains, and not an excess of
membrane.
Subsequent studies involving the imaging of immunolabeled
ceramide show that many stimuli, including the activation of
other immune cell receptors, induce the acid sphingomyelinase-
mediated formation of ceramide-rich domains (Grassmé et al.,
2002; Abdel Shakor et al., 2004; Korzeniowski et al., 2007). The
activation of cluster of differentiation 40 (CD40), a member
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of the TNF-receptor superfamily found on antigen presenting
cells, induced the formation of ceramide patches that largely
colocalized with clustered CD40 and acid sphingomyelinase
(Grassmé et al., 2002). Similar to CD95, CD40 clustering,
and subsequent signaling was inhibited by a loss of acid
sphingomyelinase activity, neutralization of cell surface
ceramide, and cholesterol depletion (Grassmé et al., 2002).
Likewise, immunofluorescence imaging of ceramide showed
the activation of Fc gamma receptor II (FcγRII), an immune
cell receptor for IgG, induced acid sphingomyelinase activity at
the cell surface and the formation of ceramide-rich membrane
patches (Abdel Shakor et al., 2004; Korzeniowski et al., 2007).
This ceramide production was required for the clustering of the
crosslinked FcγRII, subsequent receptor phosphorylation, and
signaling.
Some stimuli that ultimately triggermembrane internalization
also induce acid sphingomyelinase translocation to the cell
surface and the subsequent formation of ceramide-rich plasma
membrane domains. This includes the internalization of
pathogenic bacteria, viruses, cell-penetrating peptides, and
nanoparticles functionalized with anti-intercellular adhesion
molecule-1 (ICAM) antibodies (Grassmé et al., 1997, 2003a;
Grassmé, 2005; Verdurmen et al., 2010; Serrano et al.,
2012). Additionally, the binding of iron-loaded transferrin
to the transferrin receptor results in the formation of
ceramide-rich patches that are required for the recruitment
transferrin/transferrin receptor complexes to clathrin-coated
pits and their successive internalization (Abdel Shakor et al.,
2012).
In the majority of these studies, the biological effects of
ceramide production were hypothesized to involve changes
in lipid-lipid interactions resulting from the hydrolysis of
sphingomyelin in lipid rafts to ceramide. Cleavage of the
phosphatidylcholine head group from sphingomyelin reduces
the affinity between cholesterol and the newly formed ceramide
(Megha and London, 2004). This hypothetically promotes a
local loss of cholesterol and the formation of a ceramide-rich
domain with a negative curvature that induces vesicle formation
(Kolesnick et al., 2000; Cremesti et al., 2002; Megha and
London, 2004; Bollinger et al., 2005). An alternative mechanism
for ceramide-mediated receptor clustering and internalization
invokes ceramide’s role as a second messenger that mediates
cytoskeletal remodeling and membrane internalization through
selective ceramide-protein interactions. The ceramide produced
in the plasma membrane by acid sphingomyelinase is known
to selectively bind to and activate two protein phosphatases,
PP2A and PP1 (Chalfant et al., 1999; Canals et al., 2010,
2012). These ceramide-activated serine/threonine phosphatases
dephosphorylate ezrin, which abrogates the simultaneous
binding of ezrin to actin and the plasma membrane, causing
a loss of plasma membrane-cytoskeleton linkage, and cortical
actin remodeling (Zeidan et al., 2008; Canals et al., 2010,
2012). Therefore, selective ceramide-protein interactions may
mediate the cytoskeletal remodeling that is necessary for receptor
clustering, internalization, and transport through the cortical
actin network beneath the plasma membrane.
IMMUNOIMAGING MULTIPLE
SPHINGOLIPID SPECIES IN PARALLEL
WITHIN THE PLASMA MEMBRANE
The development of antibodies and non-toxic recombinant
versions of toxin molecules that selectively bind to distinct
sphingolipid subspecies has enabled simultaneously visualizing
the distributions of multiple sphingolipid subspecies within the
plasma membrane. Studies that imaged these new sphingolipid-
specific affinity labels suggest that different sphingolipid
subspecies are segregated within different regions of the plasma
membrane (Fujita et al., 2007, 2009; Janich and Corbeil, 2007;
Chen et al., 2008). One study probed the distributions of GM1,
GM3, and prominin-1, a cholesterol-binding protein that resides
in plasma membrane protrusions (Roper et al., 2000), on the
apical surfaces of MDCK cells (Janich and Corbeil, 2007). This
work showed that fluorescent cholera toxin B-labeled GM1
colocalized with antibody-labeled prominim-1 on microvilli on
the apical surfaces of MDCK cells, whereas fluorescent antibody-
labeled GM3 was excluded from these sites (Janich and Corbeil,
2007). In contrast, both fluorescent cholera toxin B-labeled GM1
and imunolabeled GM3 colocalized with the labeled prominin-
1 on primary cilium, which are another type of protrusion on
the apical surfaces of MDCK cells. A study that used near-
field scanning optical microscopy (NSOM) and quantum dot-
functionalized affinity labels to detect GM1 and GM3 on separate
MDCK cells also indicated GM1 andGM3were segregated on the
apical cell surface (Chen et al., 2008). In this study, the GM3 and
GM1 were primarily found on the peaks and valleys, respectively,
of the microvillus-like protrusion on the apical surface of the
MDCK cells (Chen et al., 2008).
A lack of co-localization between GM1 and GM3 on
mouse fibroblast cells was also reported by Fujimoto and
coworkers. They performed immunoelectron microscopy on
flash-frozen and freeze-fractured mouse fibroblast cells that
had been immunolabeled for GM1 and GM3 using orthogonal
antibody pairs functionalized with different diameter colloidal
gold particles (Fujita et al., 2007, 2009). Both GM3 and GM1were
clustered within separate plasma membrane domains that rarely
overlapped. Cholesterol depletion reduced the abundances of the
GM1 and GM3 clusters, which is consistent with the hypothesis
that these gangliosides reside in rafts that are dependent
on cohesive cholesterol-sphingolipid interactions (Fujita et al.,
2007). However, chilling the cells on ice prior to flash-freezing,
which was expected to promote the growth of the ordered
lipid raft domains, actually reduced the clustering of GM1
and GM3 within the plasma membrane (Fujita et al., 2007).
Interestingly, depolymerization of cellular actin by treatment
with latrunculin A reduced the number of non-overlapping
GM1 and GM3 domains in the plasma membrane, and
increased GM1 and GM3 co-clustering (Fujita et al., 2009).
Inhibition of Src-family kinases decreased the clustering of
GM3 more significantly than GM1 (Fujita et al., 2009). The
authors proposed that GM1 and GM3 might bind to different
transmembrane proteins that associate with the cytoskeleton, and
these different ganglioside-protein-cytoskeleton interactions are
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differentially influenced by cholesterol depletion and Src-family
kinase inhibition.
Altogether, the simultaneous imaging of multiple
immunolabeled ganglioside species points to the existence
of multiple types of sphingolipid domains in the plasma
membrane. These studies indicate that the mechanism for
plasma membrane organization is far more complex than one
governed by the components’ differential affinities for ordered
domains that are induced by cohesive cholesterol-sphingolipid
interactions.
IMAGING FLUOROPHORE-LABELED
SPHINGOLIPIDS WITHIN THE PLASMA
MEMBRANE
The presence of multiple different types of sphingolipid
domains within the plasma membrane was also suggested by
studies that probed the distributions of various fluorescent
sphingolipid analogs on the surfaces of mammalian cells. In
these experiments, fluorophore-labeled sphingolipid analogs
are incorporated into the plasma membranes of living cells
and imaged with fluorescence microscopy. A complication of
this approach is that the fluorescent lipid analogs can be
internalized and incorporated into intracellular membranes.
Labeled intracellular membranes, such as endosomes or vesicles,
adjacent to the plasma membrane produce regions of elevated
fluorescence that are difficult to discriminate from fluorescent
membrane patches that signify a local enrichment in the
fluorescent lipid. To avoid this complication, Tyteca and
coworkers probed the distribution of fluorescent sphingolipid
analogs in erythrocytes (Tyteca et al., 2010; D’Auria et al.,
2013), which lack nuclei, endosomes, endoplasmic reticulum,
and other membrane-bound organelles, and are also incapable
of lipid metabolism and membrane trafficking. They used
BODIPY-labeled analogs of sphingomyelin, glucosylceramide
(BODIPY-GlcCer), and lactosylceramide (BODIPY-LacCer) in
which the BODIPY fluorophore was attached to the N-acyl
fatty acid. All three of these BODIPY-labeled sphingolipid
analogs formed micron-sized domains in the plasma membranes
of erythrocytes. Similar domains were observed when other
fluorophores were used in place of BODIPY, which indicates
this sphingolipid clustering was not induced by the fluorophore
(Tyteca et al., 2010). A series of control experiments argued that
the regions of elevated BODIPY-sphingolipid fluorescence on the
erythrocytes signify plasma membrane domains enriched with
BODIPY-sphingolipids, and not membrane folds or protrusions.
Interestingly, the abundances of these BODIPY-sphingolipid
domains did not progressively increase as temperature decreased
(Tyteca et al., 2010), which argues against a phase separation-like
process.
Membrane domains enriched with BODIPY-sphingomyelin,
BODIPY-GlcCer, and BODIPY-LacCer were also detected on
nucleated cells. Compared to erythrocytes, the sphingolipid-
enriched domains appeared to be more abundant and elongated
on Chinese hamster ovary (CHO) cells (Tyteca et al., 2010).
Control experiments argued against the possibilities that these
fluorescent patches were caused by the detection of excess
membrane or the nonspecific absorption of aggregated BODIPY-
sphingolipid analogs. Double labeling experiments revealed the
BODIPY-sphingomyelin and BODIPY-LacCer formed separate
domains in the plasma membranes of CHO cells, whereas
BODIPY-GlcCer and BODIPY-LacCer colocalized within the
same domains (Tyteca et al., 2010). Additionally, a GPI-anchored
green fluorescent protein (GFP) construct colocalized with the
BODIPY-LacCer domains, but not the BODIPY-sphingomyelin
domains. The BODIPY-sphingomyelin domains were not
affected by latrunculin A-induced actin depolymerization, but
they coalesced into larger structures following depletion of ATP
or 70% of the cholesterol in CHO cells (Tyteca et al., 2010).
In a subsequent report, Tyteca and coworkers reported
BODIPY-labeled analogs of GM1 (BODIPY-GM1) and
phosphatidylcholine (BODIPY-PC) also formed micron-
scale domains in the plasma membranes of erythrocytes
(D’Auria et al., 2013). The mechanism for BODIPY-PC domain
formation was not clear. The abundances of the membrane
domains enriched with BODIPY-GM1, BODIPY-PC, BODIPY-
sphingomyelin, and BODIPY-GlcCer decreased whenmembrane
tension increased due to cell spreading (D’Auria et al., 2013).
Cholesterol depletion had little effect on the BODIPY-GlcCer
domains on erythrocytes. However, cholesterol depletion
eliminated the BODIPY-sphingomyelin and BODIPY-PC
domains (D’Auria et al., 2013) on erythrocytes, which seems
to contrast with the prior finding that cholesterol depletion
induced the formation of large BODIPY-sphingomyelin
domains on CHO cells (Tyteca et al., 2010). The abundances
of BODIPY-GlcCer and BODIPY-sphingomyelin domains
on the erythrocytes increased when the membrane-spectrin
linkage was uncoupled, and proteins involved in membrane-
spectrin anchorage colocalized with the BODIPY-sphingomyelin
domains (D’Auria et al., 2013). Overall, the lack of colocalization
between the different sphingolipid domains, their dependency on
membrane-cytoskeleton anchorage, and the differential effects
of cholesterol depletion on these domains are inconsistent with
hypothetical mechanisms of sphingolipid domain formation
driven solely by cohesive cholesterol-sphingolipid interactions.
The authors proposed that the differential sensitivity of the
various sphingolipid domains to cholesterol abundance may
indicate regulation of membrane-cytoskeleton anchorage
by cholesterol (D’Auria et al., 2013). Consistent with their
hypothesis, the band 3 anion transport protein, which links the
plasma membrane to the underlying cytoskeleton, reportedly
has an affinity for cholesterol (Klappauf and Schubert, 1977;
Schubert and Boss, 1982).
SUPER-RESOLUTION FLUORESCENCE
IMAGING OF FLUORESCENT
SPHINGOLIPID ANALOGS IN THE PLASMA
MEMBRANE
The expectation that lipid rafts are too small and dynamic
to be detected with diffraction-limited fluorescence microscopy
motivated attempts to detect lipid rafts with super-resolution
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fluorescence microscopy techniques (Owen et al., 2012). Instead
of imaging the sphingolipids and cholesterol in parallel at high
spatial resolution, many studies focused on tracking the diffusion
of fluorescent sphingolipid analogs or other putative raft
components in the plasma membrane. The cohesive cholesterol-
and sphingolipid interactions that hypothetically induce lipid raft
formation would hinder the diffusion of these components in the
plasma membrane, producing a detectable anomalous diffusion
that would be sensitive to cholesterol depletion.
Perhaps the most influential super-resolution imaging
studies of membrane organization revealed complex lipid
dynamics that were ultimately inconsistent with partitioning
into liquid-ordered membrane domains produced by favorable
cholesterol-and sphingolipid interactions (Hiramoto-Yamaki
et al., 2014; Honigmann et al., 2014; Andrade et al., 2015;
Sevcsik et al., 2015). Stimulated emission depletion (STED)
fluorescence microscopy imaging demonstrated fluorophore-
labeled sphingomyelin, GM1, and a GPI-anchored protein were
temporarily trapped within 20-nm-diameter areas in the plasma
membrane of living cells, and this trapping was cholesterol-
dependent (Eggeling et al., 2009). In comparison, identically
labeled phosphatidylethanolamine appeared to diffuse freely in
the membrane (Eggeling et al., 2009), which implied that lipid-
cytoskeleton interactions were not responsible for the anomalous
cholesterol-dependent sphingolipid diffusion. Noteworthy,
this finding of unhindered phosphatidylethanolamine diffusion
conflicts with a previous single molecule tracking study (Fujiwara
et al., 2002), and subsequent STED-FCS and single molecule
tracking studies reported by these authors and others (Andrade
et al., 2015; Fujiwara et al., 2016; Komura et al., 2016). Although,
the authors of the STED study never concluded that the
cholesterol-dependent trapping of sphingomyelin, GM1 and
GPI-anchored proteins was indicative of tiny lipid rafts, their
results were often cited by others as support for the lipid raft
hypothesis (Lingwood and Simons, 2010; Levental and Veatch,
2016). Subsequent studies showed that the transient trapping
of the fluorescent sphingolipids and GPI-anchored proteins in
the plasma membrane were both cholesterol- and cytoskeleton-
dependent, and likely reflected binding to immobile membrane
proteins, and not entrapment in lipid rafts (Mueller et al., 2011;
Honigmann et al., 2014; Sevcsik et al., 2015). Super-resolution
fluorescence microscopy imaging also revealed fluorescent
cholesterol analogs diffuse freely in the plasma membranes of
living cells (Hiramoto-Yamaki et al., 2014; Honigmann et al.,
2014), which argues against the existence of lipid rafts.
DIRECT IMAGING OF SPHINGOLIPID
DISTRIBUTION IN THE PLASMA
MEMBRANE WITH HIGH-RESOLUTION
SIMS
High-resolution SIMS performed on a NanoSIMS 50 instrument
was used to decisively answer the question: How are cholesterol
and sphingolipids distributed in the plasma membranes of
intact mouse fibroblast cells? Transfected NIH 3T3 mouse
fibroblast cells that stably expressed influenza hemagglutinin
(Clone 15 cell line) were employed in these experiments because
the micrometer-scale hemagglutinin clusters in their plasma
membranes were hypothesized to colocalize with lipid rafts
(Scheiffele et al., 1997; Hess et al., 2005; Polozov et al., 2008).
This hypothesis suggested that these cells had sphingolipid- and
cholesterol-rich membrane domains that could easily be detected
with high-resolution SIMS. Untransfected NIH 3T3 mouse
fibroblast cells were also analyzed for comparison. Distinct stable
isotopes, 15N and 18O, were metabolically incorporated into the
sphingolipids and cholesterol, respectively, in living Clone 15 and
NIH 3T3 cells (Klitzing et al., 2013). High levels of rare isotope
incorporation into the cellular sphingolipids and cholesterol were
achieved to ensure that the majority of the sphingolipid and
cholesterol molecules in the plasma membrane could be detected
and imaged with high-resolution SIMS.
The low-voltage SEM image (Figure 1A) shows the
morphology of a representative chemically fixed NIH 3T3
mouse fibroblast cell (Frisz et al., 2013a). High-resolution SIMS
imaging of the lipid-specific isotope enrichments on the cell
showed the plasma membrane contained 15N-sphingolipid
domains, evidenced by statistically significant local elevations in
15N-enrichment, that were as large as 2 µm across (Figure 1B;
Frisz et al., 2013a,b). In contrast, 18O-cholesterol was uniformly
distributed within the plasmamembrane (Figure 1C) (Frisz et al.,
2013a,b), and was not enriched at the sphingolipid domains
(Frisz et al., 2013a). Similar sphingolipid and cholesterol
distributions were observed on multiple other NIH 3T3 mouse
fibroblast cells and Clone 15 cells (Frisz et al., 2013a,b).
The finding of sphingolipid domains with dimensions
sufficient for detection with fluorescence microscopy is
consistent with the abovementioned reports of micron-scale
domains of fluorescent sphingolipid analogs in the membranes
of living cells (Tyteca et al., 2010; D’Auria et al., 2013). Though
unexpected, the relatively uniform cholesterol distribution
observed is consistent with previous reports that intrinsically
fluorescent sterols are evenly distributed in the membranes of
mammalian cells (Wustner, 2007; Wüstner and Faergeman,
2008). This uniform cholesterol distribution is also supported by
subsequently published super-resolution fluorescence imaging
studies that showed fluorescent cholesterol analogs are not
trapped in nanoscale domains within the plasma membranes
of living cells (Hiramoto-Yamaki et al., 2014; Honigmann
et al., 2014). Additionally, a comprehensive series of control
experiments rigorously excluded the possibility that the lipid
organizations imaged with high-resolution SIMS were artifacts
of analysis. First, the imaging of fluorescent sphingolipids
on fibroblast cells that had been metabolically labeled with
fluorescent sphingosine showed that large sphingolipid domains
were visible on the living cells, and the shapes, sizes, and
positions of these fluorescent sphingolipid domains were not
altered by glutaraldehyde fixation (Figures 2A–C; Frisz et al.,
2013b). Thus, fixation did not induce sphingolipid clustering,
and the lateral diffusion of lipids within the membrane during
fixation did not disperse the sphingolipid domains that were
present in the plasma membrane while the cells were alive.
Next, experiments in which the rare stable isotope, 13C, was
incorporated into all lipid species and imaged in parallel with
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FIGURE 1 | SEM and SIMS images show the morphology of a NIH 3T3
mouse fibroblast cell and the sphingolipid and cholesterol distribution
in its plasma membrane. (A) SEM image of a NIH 3T3 fibroblast. (B)
Montage of 15N-enrichment high-resolution SIMS images shows
15N-sphingolipid domains (orange and yellow regions) in the plasma
membrane. (C) The 18O-enrichment images that were acquired in parallel
show a relatively even 18O-cholesterol distribution in the plasma membrane.
Color scales show the number of times that the 15N- or 18O-enrichment is
greater than standard abundance. Montages consist of several high-resolution
SIMS images that were acquired with 87-nm-lateral resolution. Adapted with
permission from research originally published in Frisz et al. (2013a). © The
American Society for Biochemistry and Molecular Biology.
15N-sphingolipids confirmed that the cells’ plasma membranes
were intact. Importantly, lack of 13C-enrichment, which would
signify an excess of all lipid species, at the 15N-enriched
domains conclusively demonstrated that the local elevations in
15N-enrichment were not due to the detection of intracellular
vesicles, organelles, or membrane folds, which would produce
a co-committant increase (Figures 2D–F; Frisz et al., 2013b).
Finally, control experiments ruled out the possibilities that the
15N-enriched domains on the cells were caused by isotope-
labeled lipid precursors nonspecifically adsorbed to the cells, cell
topography, temperature-induced domain formation, or sample
preparation (Frisz et al., 2013b). Published reports have also
established that high-resolution SIMS imaging does not alter
the lipid distribution in phase-separated supported lipid bilayers
(Kraft et al., 2006; Anderton et al., 2011), and this technique has
the sensitivity to detect nanoscale domains enriched with GM1
and cholesterol in model lipid membranes (Lozano et al., 2013).
The lack of cholesterol enrichment in the sphingolipid
domains detected on the fibroblast cells suggests that the
self-organizing potential of cholesterol and sphingolipids is
not responsible for plasma membrane organization. This
possibility was further assessed by imaging the distributions
of 15N-sphingolipids and 18O-cholesterol following cholesterol
depletion. SEM images of mouse fibroblast cells that had been
treated with methyl-β-cyclodextrin, which reduced the cellular
cholesterol by 30%, showed cholesterol depletion altered cell
morphology and reduced cell spreading. High-resolution SIMS
imaging revealed the abundance of 15N-sphingolipid domains
in the plasma membrane also decreased, but the remaining
18O-cholesterol in the plasma membrane still appeared to
be relatively uniformly distributed (Frisz et al., 2013a). No
significant difference in the 18O-cholesterol abundance in the
sphingolipid domains and comparably sized non-domain regions
was detected. Other mβCD-treated Clone 15 cells had similar
cholesterol and sphingolipid distributions (Frisz et al., 2013a).
Based on the lack of cholesterol enrichment in the sphingolipid-
enriched domains either before or after cholesterol depletion,
favorable cholesterol-sphingolipid interactions cannot be the
driving force for plasma membrane organization.
The resemblance in the sphingolipid and cholesterol
distributions in the plasma membranes of the Clone 15 and NIH
3T3 mouse fibroblast cells suggests the sphingolipid domains
were not produced by favorable hemagglutinin-sphingolipid
interactions. However, hemagglutinin might have an affinity for
sphingolipids in the plasma membrane, which would cause the
hemagglutinin to accumulate within the sphingolipid-enriched
domains. This possibility was assessed by studying the stably
expressed influenza hemagglutinin clusters in the membranes
of uninfected Clone 15 cells instead of those in the membranes
of influenza-infected cells to ensure that other viral proteins
did not affect hemagglutinin localization within the plasma
membrane. To permit visualization, the hemagglutinin on
the metabolically labeled Clone 15 cells was labeled with a
mouse anti-hemagglutinin antibody followed by an anti-mouse
secondary antibody conjugated to a fluorinated colloidal gold
particle (Wilson et al., 2012). High-resolution SIMS imaging of
the 19F− ions distinctive to the immunolabeled hemagglutinin in
parallel with the 15N-sphingolipids and 18O-cholesterol revealed
the fluorine-rich patches that located the hemagglutinin clusters
were neither enriched with cholesterol nor well colocalized
with 15N-sphingolipid domains (Figures 3A–C; Wilson et al.,
2015). The low co-localization between the hemagglutinin
and sphingolipid domains was confirmed by complementary
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FIGURE 2 | Control experiments exclude possible artifacts caused by cell fixation or the detection of excess membrane caused by intracellular
membranes adjacent to the plasma membrane. Total internal reflectance microscopy images (background subtracted and averaged through the stack) of
BODIPY-sphingolipids in the plasma membrane of a fibroblast (A,B) before and (C) after fixation. Enlargement of outlined region in (A) shows no change in the
domains that were present (B) in the living cell (C) after glutaraldehyde fixation. Fluorescent micro-extensions are artifacts of background correction. Reproduced with
permission from Frisz et al. (2013b). Copyright 2013 National Academy of Sciences, U.S.A. The (D) secondary electron, (E) 13C-enrichment, and (F) 15N-enrichment
images acquired with high-resolution SIMS shows that the 15N-sphingolipid domains do not coincide with cell projections, folds, or other excesses of cellular lipids,
which are labeled with carbon-13 and thus, would produce a co-elevation in 13C-enrichment. The color scale represents the indicated isotope enrichment measured
at each pixel compared to unlabeled cells. Adapted with permission from Frisz et al. (2013b). Copyright 2013 National Academy of Sciences, U.S.A.
experiments in which immunolabeled hemagglutinin and
fluorescent sphingolipids in living Clone 15 cells were imaged
with fluorescence microscopy (Figures 3D–F; Frisz et al.,
2013b). The consistency between the findings of these two
complementary techniques discounts the prospect that cell
fixation or antibody labeling altered the membrane organizations
observed with either technique. These findings disprove the
hypothesis that hemagglutinin clustering is caused by an
attraction to ordered plasma membrane domains that are
enriched with cholesterol and sphingolipids. This conclusion is
consistent with biophysical studies that indicated hemagglutinin
is not located within cholesterol-rich liquid-ordered membrane
domains (Hess et al., 2005, 2007; Polozov et al., 2008; Nikolaus
et al., 2010).
The finding that cholesterol depletion reduced both cell
spreading and sphingolipid domain abundance in the plasma
membrane is consistent with the alternative hypothesis that
the cytoskeleton and its associated proteins divide the plasma
membrane into distinct lipid domains (Gheber and Edidin,
1999; Douglass and Vale, 2005; Kusumi et al., 2005; Hiramoto-
Yamaki et al., 2014). This alternative hypothesis was also tested
by using high-resolution SIMS to image the 15N-sphingolipid
distributions in the plasma membranes of NIH 3T3 cells
that were treated with latrunculin A to depolymerize their
cytoskeletons. Actin depolymerization altered cell morphology
(Figure 4A) and eliminated the vast majority of large 15N-
sphingolipid domains in the plasma membrane (Figure 4B;
Frisz et al., 2013b). This finding confirms the hypothesis
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FIGURE 3 | High-resolution SIMS and complementary immunofluorescence imaging shows hemagglutinin does not cluster in plasma membrane
domains that are enriched with cholesterol and sphingolipids. High-resolution SIMS images of a region on a mouse fibroblast cell that stably expressed
influenza hemagglutinin (Clone 15 cell line). (A) High-resolution SIMS image of the 19F− counts shows the distribution of immunolabeled hemagglutinin in the plasma
membrane. Comparison to the (B) 15N-enrichment and (C) 18O-enrichment images that were simultaneously acquired indicates hemagglutinin is not located in
cholesterol- and sphingolipid-enriched domains. Reprinted from Wilson et al. (2015). Copyright (2015) with permission from Elsevier. Total internal reflectance
microscopy detection of (D) BODIPY-sphingolipids (green) and (E) hemagglutinin (red) in the plasma membrane of a living Clone 15 cell. (F) Overlay shows little
colocalization between the sphingolipids and hemagglutinin (yellow). Scale bar is 5 µm. Reproduced with permission from Frisz et al. (2013b). Copyright 2013
National Academy of Sciences, U.S.A.
FIGURE 4 | Secondary electron and SIMS images of a NIH 3T3 fibroblast cell treated with latrunculin A to depolymerize the actin cytoskeleton. (A)
Secondary electron images show cell morphology. Secondary electrons were not detected at the bottom of the image due to the low beam current used. (B)
15N-enrichment images acquired with high-resolution SIMS show few 15N-sphingolipid domains following actin depolymerization. Color scales show the number of
times that the 15N-enrichment is greater than standard abundance. Reproduced with permission from research originally published in Frisz et al. (2013a). © The
American Society for Biochemistry and Molecular Biology.
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that the cytoskeleton and its associated membrane proteins
corral the sphingolipids within distinct domains in the plasma
membrane.
IMPLICATIONS FOR PLASMA MEMBRANE
ORGANIZATION HYPOTHESES
Independent experiments performed with complementary
imaging techniques have yielded data that undeniably refutes the
hypothesis that cohesive sphingolipid-cholesterol interactions
are the driving force for plasma membrane organization. These
findings include: (1) the lack of cholesterol- or hemagglutinin-
enrichment in the sphingolipid domains that were detected
in the plasma membranes of fibroblast cells with high-
resolution SIMS (Frisz et al., 2013a; Wilson et al., 2015); (2)
the unhindered diffusion of cholesterol analogs detected in the
membranes of living cells with super-resolution fluorescence
imaging (Hiramoto-Yamaki et al., 2014; Honigmann et al.,
2014); and (3) the transient trapping of other putative raft
components is inconsistent with interactions with rafts or lipid
phase separation (Hiramoto-Yamaki et al., 2014; Honigmann
et al., 2014; Sevcsik et al., 2015). Thus, although favorable
cholesterol-sphingolipid interactions induce the formation of
liquid-ordered domains that are enriched with cholesterol and
sphingolipids in model membranes (Sankaram and Thompson,
1990) and membrane blebs (Baumgart et al., 2003, 2007), these
interactions do not control lipid organization in the plasma
membranes of actual cells. Given that cholesterol-sphingolipid
interactions are a cornerstone of the lipid raft hypothesis and
both high-resolution SIMS and super-resolution fluorescence
techniques failed to detect lipid rafts, these results not only argue
against the existence of rafts, they conclusively disprove their
existence.
The discrepancies between experimental data and predictions
of the raft hypothesis cannot be rectified by incorporating
additional protein-protein or protein-lipid interactions into
a revised model that is still based on cohesive sphingolipid-
cholesterol interactions. Instead, alternative hypotheses that
do not involve cohesive sphingolipid-cholesterol interactions
must be developed, investigated, and discarded if they prove
inconsistent with experimental results. These alternative
hypotheses should account for the following observations:
i. The diffusion and distribution of proteins and lipids is
influenced by the actin cytoskeleton (Fujiwara et al., 2002,
2016; Mueller et al., 2011; D’Auria et al., 2013; Frisz et al.,
2013a,b; Honigmann et al., 2014; Andrade et al., 2015; Sevcsik
et al., 2015; Komura et al., 2016).
ii. Actin accumulates under clusters of crosslinked membrane
proteins (Ash et al., 1977; Bourguignon and Singer, 1977;
Kellie et al., 1983; Pierini et al., 1996; Harder and Simons,
1999; Rodgers and Zavzavadjian, 2001; Delaguillaumie et al.,
2004;Wilson et al., 2004; Goswami et al., 2008; Gowrishankar
et al., 2012; Gudheti et al., 2013).
iii. Different sphingolipid subspecies form separate
microdomains in the plasma membrane, and each domain
of different sphingolipid subspecies may contain distinctly
different membrane proteins (Fujita et al., 2007, 2009; Janich
and Corbeil, 2007; Chen et al., 2008; Tyteca et al., 2010).
iv. Cellular processes are sensitive to sphingolipid catabolism
and inhibitors of sphingolipid biosynthesis (Wiegmann et al.,
1994; Tepper et al., 1995; Grassmé et al., 1997, 2001a,b, 2003a;
Brenner et al., 1998; Junge et al., 1999; Grullich et al., 2000;
Cremesti et al., 2001; Paris et al., 2001; Grassmé et al., 2003b;
Abdel Shakor et al., 2004, 2012; Grassmé, 2005; Korzeniowski
et al., 2007; Verdurmen et al., 2010; Serrano et al., 2012).
v. Cholesterol depletion affects protein clustering and cell
signaling (Stauffer and Meyer, 1997; Harder et al., 1998;
Harder and Simons, 1999; Huby et al., 1999; Janes et al., 1999;
Cremesti et al., 2001; Grassmé et al., 2001a; Mitchell et al.,
2002; Lacour et al., 2004; Hess et al., 2005).
The alternative hypothesis that the plasma membrane is
segregated by cortical actin and its associated proteins is
consistent with the numerous observations that the distribution
and diffusion of lipids and proteins in the plasma membrane
is influenced by drugs that affect cytoskeletal integrity (Kusumi
and Sako, 1996; Ritchie et al., 2003; Kusumi et al., 2005). In
this model, the cytoskeleton and its associated proteins establish
diffusion barriers, and the energy-dependent constant delivery
and removal of membrane proteins and lipids at the plasma
membrane creates lateral variations in component abundance
(Gheber and Edidin, 1999; Turner et al., 2005; Lavi et al.,
2007; Fan et al., 2010). Indeed, localized trafficking hubs in the
plasma membrane have been shown to produce stable domains
of distinct protein compositions (Deutsch et al., 2012; Fox
et al., 2013). Whether the sphingolipid domains in the plasma
membrane are local hubs for sphingolipid trafficking might be
assessed by performing high-resolution SIMS in a depth profiling
mode to produce three-dimensional images of the intracellular
sphingolipid distribution (Yeager et al., 2016).
Nonetheless, the true mechanism for plasma membrane
organization is probably far more complex than the current
cytoskeleton-based model. For example, cytoskeletal barriers
combined with endocytosis and exocytosis events may not fully
explain the reported redistribution of crosslinked gangliosides
within the plasma membrane during capping. Therefore,
the previous hypothesis that individual sphingolipid species
selectively and reversibly interact with distinct proteins that are
associated with the actin cortex may need to be reconsidered.
These sphingolipid-protein interactions may be transient,
regulated by external stimuli (i.e., ligand binding), and specific,
where different sphingolipid subspecies bind to different protein
partners. Such specific, inducible, and transient sphingolipid-
protein interactions could direct the segregation of different
glycosphingolipid species within different microdomains in the
plasma membrane (Fujita et al., 2007, 2009; Janich and Corbeil,
2007; Chen et al., 2008), and mediate their clustering in
response to crosslinking. This hypothetical mechanism may also
account for colocalization between specific glycosphingolipid
species and distinct proteins in the plasma membrane (D’Auria
et al., 2013), and the accumulation of actin observed beneath
clusters of membrane proteins (Ash et al., 1977; Bourguignon
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and Singer, 1977; Kellie et al., 1983; Pierini et al., 1996;
Harder and Simons, 1999; Rodgers and Zavzavadjian, 2001;
Delaguillaumie et al., 2004; Wilson et al., 2004; Goswami
et al., 2008; Gowrishankar et al., 2012; Gudheti et al., 2013).
Given the existence of lipid binding proteins that selectively
interact with phosphatidylinositols, phosphatidylcholines, and
phosphatidylserines (Lemmon, 2008; Stahelin, 2009; Glatz, 2015),
other lipid species may also selectively bind to distinctive proteins
that are associated with the actin cortex.
The sensitivity of many cellular processes, including antigen
capping and apoptosis, to enzymes that induce sphingolipid
catabolism or drugs that inhibit sphingolipid biosynthesis can
be attributed to the established role of sphingolipids and their
metabolites as second messengers in diverse signaling processes
(Hannun and Obeid, 2008; Zeidan et al., 2008; Kim et al.,
2009; Milhas et al., 2010; Spiegel and Milstien, 2011; Canals
et al., 2012). The cholesterol sensitivity of membrane protein
clustering and other events that occur in the plasma membrane
may be indicative of specific cholesterol-protein interactions
(Lange and Steck, 2016). Cholesterol is known to selectively
bind to specific sites on a few integral membrane proteins,
thereby regulating their conformation and activity (Hanson et al.,
2008; Fürst et al., 2014; Clay et al., 2015). The observation that
cholesterol depletion reduces cell spreading may suggest that
cholesterol binding regulates plasma membrane attachment to
the cytoskeleton. Alternatively, cholesterol may indirectly affect
membrane attachment to the cytoskeleton via its effects on
the abundance of phosphoinositides in the plasma membrane,
which help to recruit cytosolic proteins to the plasma membrane
(Kwik et al., 2003). A combination of affinity labeling, mass
spectrometry detection of protein complexes associated with
distinct lipids or cholesterol, and super-resolution imaging of
suspected binding partners in cells will be required to evaluate
this hypothesis.
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